A Phase II Trial of SU5416 (NSC #696819) [semaxanib] in Previously Treated Patients With Advanced, Metastatic and/or Locally Recurrent Soft Tissue Sarcomas
Phase of Trial: Phase II
Latest Information Update: 07 Feb 2007
At a glance
- Drugs Semaxanib (Primary)
- Indications Gastrointestinal cancer
- Focus Therapeutic Use
- 07 Feb 2007 New trial record.